GPT Healthcare Limited has informed the Exchange regarding Resignation of Mr Debashis Dhar as Senior Vice President and Chief Business Development Officer of the company w.e.f. April 02, 2026.
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 1.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GPT Healthcare Limited has announced the resignation of Mr. Debashis Dhar from his position as Senior Vice President and Chief Business Development Officer, effective from the close of business hours on April 2, 2026. Mr. Dhar was also classified as one of the Senior Management Personnel (SMP) of the company. The reason cited for his resignation is personal reasons. The company has filed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No immediate replacement or succession plan has been mentioned in the filing.
The departure of a senior management personnel responsible for business development could create a short-term void in leadership continuity. Shareholders should monitor for announcements regarding his replacement, as this role is critical for the company's growth strategy.